Bacterial polysaccharides in sickness and in health

References

1. Arrecubieta C., Lopez R., Garcia E. 1994; Molecular charac-terization of cap3A. gene from the operon required for the synthesis of the capsule of Streptococcus pneumoniae type 3a: sequencing of mutations responsible for the unencapsulated phenotype and localization of the capsule cluster on the pneumococcal chromosome.. J Bacteriol 176:6375–6383
   [Google Scholar]
2. Balazs E.A., Freeman M.I., Kloti R. 1972; Hyaluronic acid and replacement of vitreous and aqueous humor.. Mod Probl Ophthalmol 10:3–21
   [Google Scholar]
3. Beuvery E.C., Miedema F., van Delft R., Haverkamp J. 1983; Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.. Infect Immun 40:39–45
   [Google Scholar]
4. Bhattacharjee A.K., Jennings H.J., Kenny C.P., Martin A., Smith I.C.P. 1975; Structural determination of the sialic acid polysaccharide antigens of Neisseria menigitidis serogroup B and serogroup C with carbon 13 nuclear magnetic resonance.. J Biol Chem 250:1926–1932
   [Google Scholar]
5. Booy R., Moxon E.R. 1991; Immunisation of infants against Haemophilus influenzae type b in the UK.. Arch Dis Child 66:1251–1254
   [Google Scholar]
6. Boulnois G.J., Roberts I.S. 1990; Genetics of capsular polysaccharide production in bacteria.. Curr Top Microbiol Immunol 150:1–18
   [Google Scholar]
7. Boulnois G.J., Roberts I.S., Hodge R., Hardy K., Jann K., Timmis K.N. 1987; Further analysis of the cloned K1 capsule biosynthesis genes of Escherichia coli: definition of three functional regions for capsule production.. Mol & Gen Genet 200:242–246
   [Google Scholar]
8. Bronner D., Sieberth V., Pazzani C., Roberts I.S., Boulnois G.J., Jann B., Jann K. 1993a; Expression of the capsular K5 polysaccharide of Escherichia coli: biochemical and electron microscopic analyses of mutants with defects in region 1 of the K5 gene cluster.. J Bacteriol 175:5984–5992
   [Google Scholar]
9. Bronner D., Sieberth V., Pazzani C., Smith A.N., Boulnois G.J., Roberts I.S., Jann B., Jann K. 1993b; Synthesis of the K5 (group II) capsular polysaccharide in transport-deficient recombinant Escherichia coli.. FEMS Microbiol Lett 113:279–284
   [Google Scholar]
10. Broome C.V. 1987; Epidemiology of Haemophilus influenzae type b infections in the United States.. Pediatr Infect Dis J 6:779–782
    [Google Scholar]
11. Brown E.J., Joiner K.A., Gaither T.A., Hammer C.H., Frank M.M. 1983; The interaction of C3b bound tp pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator) and properdin factor B of the human complement system.. J Immunol 131:409–415
    [Google Scholar]
12. Brzoska P., Signer E.R. 1991; IpsZ, a lipopolysaccharide gene involved in the symbiosis of Rhizobium meliloti.. J Bacteriol 173:3235–3237
    [Google Scholar]
13. Byrom D. 1991; Microbial cellulose.. In Biomaterials: Novel Materials from Biological Sources pp. 263–284 Byrom D. Edited by Basingstoke: Macmillan Publishers;
    [Google Scholar]
14. Cadoz M., Armand J., Arminjon F., Gire R., Lafaix C. 1985; Tetravalent (A, C, Y, W135) meningococcal vaccine in children: immunogenicity and safety.. Vaccine 3:340–342
    [Google Scholar]
15. Chiba S., Kitagawa H., Myoshi T. 1988; Fermentative manufacture of high molecular weight hyaluronic acid.. Patent JP 63129991.
    [Google Scholar]
16. Cho J.-W., Troy F.A. 1994; Poly sialic acid engineering: synthesis of polysialylated neoglycosphingolipids by using poly- sialyltransferase from neuroinvasive Escherichia coli Kl.. Proc Natl Acad Sci USA 91:11427–11431
    [Google Scholar]
17. Chu C., Schneerson R., Robbins J.B., Rastogi S.C. 1983; Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal 6A polysaccharide-protein conjugates.. Infect Immun 40:245–256
    [Google Scholar]
18. Cieslewicz M., Steenbergen S.M., Vimr E.R. 1993; Cloning, sequencing, expression and complementation analysis of theEscherichia coli Kl kps region 1 gene kpsE and identification of an upstream open reading frame encoding a protein with homology to GutQ.. J Bacteriol 175:8018–8023
    [Google Scholar]
19. Clarke-Sturman A.J., den Ottelander D., Sturla P.L. 1989; Succinoglycan. A new biopolymer for the oilfield.. In Oil-field Chemistry: Enhanced Recovery and Production Stimulation pp. 157–168 Borchardt J.K., Yen T.F. Edited by Washington, DC: American Chemical Society;
    [Google Scholar]
20. Costerton J.W., Irvin R.T., Cheng K.-J. 1981; The bacterial glycocalyx in nature and disease.. Annu Rev Microbiol 35:299–324
    [Google Scholar]
21. Cross A.S. 1990; The biologic significance of bacterial encapsulation.. Curr Top Microbiol Immunol 150:87–98
    [Google Scholar]
22. Cross A.S., Sadoff J.C., Kelly N., Bernton E., Gemski P. 1989; Pre-treatment with recombinant murine necrosis factor and murine interleukin-1 protects mice from lethal bacterial infection.. J Exp Med 169:2021–2027
    [Google Scholar]
23. De Angelis P.L., Papaconstantinou J., Wegel P.H. 1993; Isolation of a Streptococcus pyogenes gene locus that directs Hyaluran biosynthesis in acapsular mutants and in heterologous bacteria.. J Biol Chem 268:14568–14571
    [Google Scholar]
24. Dillard J.P., Yother J. 1994; Genetic and molecular charac-terisation of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3.. Mol Microbiol 12:959–972
    [Google Scholar]
25. Dougherty B., van de Rijn I. 1994; Molecular characterization of has A from an operon required for hyaluronic acid synthesis in group A Streptococci.. J Biol Chem 269:169–175
    [Google Scholar]
26. Edwards M.S., Kasper D.L., Jennings H.J., Baker C.J., Nicholson-Weller A. 1982; Capsular sialic acid prevents activation of the alternative pathway by type III group B streptococci.. J Immunol 128:1278–1283
    [Google Scholar]
27. Ellwood D.C. 1988; Hyaluronic acid derivatives as sustained- release pharmaceuticals.. Patent EP 296740.
    [Google Scholar]
28. Eskola J., Kayhty H., Takala A.K. 1990; A randomised, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.. N Engl J Med 323:1381–1387
    [Google Scholar]
29. Finke A., Jann B., Jann K. 1990; CMP-KDO synthetase activity in Escherichia coli expressing different capsular polysaccharides.. FEMS Microbiol Lett 69:129–134
    [Google Scholar]
30. Finne J. 1982; Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain.. J Biol Chem 261:11966–11970
    [Google Scholar]
31. Frosch M., Muller A. 1993; Phospholipid substitution of capsular polysaccharides and mechanisms of capsule formation in Neisseria meningitidis.. Mol Microbiol 8:483–493
    [Google Scholar]
32. Frosch M., Weisgerber C., Meyer T.F. 1989; Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B.. Proc Natl Acad Sci USA 86:1669–1673
    [Google Scholar]
33. Frosch M., Edwards U., Bousset K., Krauβe B., Weisgerber C. 1991; Evidence for a common molecular origin of capsular gene loci in gram-negative bacteria expressing group II capsular polysaccharides.. Mol Microbiol 5:1251–1263
    [Google Scholar]
34. Garcia E., Garcia P., Lopez R. 1993; Cloning and sequencing of a gene involved in the synthesis of the capsular polysaccharide of Streptococcus pneumoniae type 3.. Mol & Gen Genet 239:188–195
    [Google Scholar]
35. Goldman R.C., Kohlbrenner W.E. 1985; Molecular cloning of the structural gene coding for CTP: CMP-3-deoxy-D-manno-octulo- sonate cytidyltransferase from Escherichia coli.. J Bacteriol 163:256–261
    [Google Scholar]
36. Hardingham T., Muir H. 1972; The specific interaction of hyaluronic acid with cartilage proteoglycans.. Biochim Biophys Acta 279:401–405
    [Google Scholar]
37. Horwitz M.A., Silverstein S.C. 1980; Influence of the Escherichia coli capsule on complement fixation and on phagocytosis.. J Clin Invest 65:82–94
    [Google Scholar]
38. Hosoya H., Kimura M., Endo H. 1989; Hyaluronic acid and its manufacture with hyaluronidase-deficient Streptococcus mutant.. Patent JP 01067196.
    [Google Scholar]
39. Howard C.J., Glynn A.A. 1971; The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.. Immunology 20:767–777
    [Google Scholar]
40. Jann K., Jann B. 1987; Polysaccharide antigens of Escherichia coli.. Rev Infect Dis 9:517–526
    [Google Scholar]
41. Jeanloz R.W., Forchielli E. 1950; Studies on hyaluronic acid and related substances. I. Preparation of hyaluronic acid and derivatives from human umbilical cord.. J Biol Chem 186:495–511
    [Google Scholar]
42. Jennings H.J. 1990; Capsular polysaccharides as vaccine candidates.. Curr Top Microbiol Immunol 150:97–128
    [Google Scholar]
43. Jennings H.J., Brisson J.-P., Kulakowska M., Michon F. 1993; Polysialic acid vaccines against meningitis caused by Neisseria meningitidis and Escherichia coli.. In Polysialic Acid from Microbes to Man pp. 25–38 Roth J., Rutishauser U., Troy F.A. Edited by Basel: Birkhauser-Verlag;
    [Google Scholar]
44. Keller N., Olejnk O., Abelson M.B. 1987; Sustained release compositions containing polysaccharides especially hyaluronic acid for injection into the eye.. Patent EP 244178.
    [Google Scholar]
45. Kim K.S., Kang J.H., Cross A.S. 1986; The role of capsular antigens in serum resistance and in vivo virulence of Escherichia coli.. FEMS Microbiol Lett 35:275–278
    [Google Scholar]
46. Kjellen L., Lindahl U. 1991; Proteoglycans: structure and interactions.. Annu Rev Biochem 60:443–475
    [Google Scholar]
47. Kroll J.S., Zamze S., Loynds B., Moxon E.R. 1989; Common organization of chromosomal loci for the production of different capsular polysaccharides in Haemophilus influenzae.. J Bacterial 171:3343–3347
    [Google Scholar]
48. Kroll J.S., Loynds B., Brophy L.N., Moxon E.R. 1990; The bex locus in encapsulated Haemophilus influenzae: a chromosomal region involved in capsule polysaccharide export.. Mol Microbiol 4:1853–1862
    [Google Scholar]
49. Kuo J., Douglas M., Ree H.K., Lindberg A.A. 1995; Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 1& conjugate vaccines.. Infect Immun 63:2706–2713
    [Google Scholar]
50. Lee C.Y. 1992; Cloning of genes affecting capsule expression in Staphylococcus aureus strain M.. Mol Microbiol 6:1515–1522
    [Google Scholar]
51. Lett E., Klopfenstein C., Klein J.-P., Scholler M., Wachsmann D. 1995; Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes.. Infect Immun 63:2645–2651
    [Google Scholar]
52. Lindahl U., Lidholt K., Spillmann D., Kjellen L. 1994; More to heparin than anticoagulation.. Thromb Res 75:1–32
    [Google Scholar]
53. Linton J.D., Ash S.G., Huybrechts L. 1991; Microbial polysaccharides.. In Bio materials: Novel Materials from Biological Sources pp. 215–262 Byrom D. Edited by Basingstoke: Macmillan Publishers;
    [Google Scholar]
54. Mali M., Andtfolk H., Miettinen H., Jalkanen M. 1994; Suppression of tumor cell growth by syndecan-1 ectodomain.. J Biol Chem 269:27795–27798
    [Google Scholar]
55. Martinsen A., Skjaek-Braek G., Smidsrod O. 1989; Alginate as immobilisation material. I. Correlation between chemical and physical properties of alginate gel beads.. Biotechnol Bioeng 33:79–89
    [Google Scholar]
56. Miller D., O’Connor P., Williams J. 1977; Use of Na-hyaluronate during intraocular lens implantation in rabbits.. Ophthalmic Surg 8:58–61
    [Google Scholar]
57. Moradi-Araghi A., Beardmore D.H., Stahl G.A. 1988; The application of gels in enhanced oil recovery: theory, polymers and crosslinker systems.. In Water-Soluble Polymers for Petroleum Recovery pp. 299–312 Stahl G.A., Schulz D.N. Edited by New York: Plenum Press;
    [Google Scholar]
58. Morris V.J. 1990; Science, structure and applications of microbial polysaccharides.. In Gums and Stabilisers for the Food Industry pp. 315–328 Phillips G.O. Edited by Oxford: IRL;
    [Google Scholar]
59. Morris V.J., Franklin D., I'Anson K. 1983; Rheology and microstructure of dispersions and solutions of the microbial polysaccharide from Xanthomonas campestris (xanthan gum).. Carbo- hydr Res 121:13–30
    [Google Scholar]
60. Moxon E.R., Kroll J.S. 1990; The role of bacterial poly-saccharide capsules as virulence factors.. Curr Top Microbiol Immunol 150:65–86
    [Google Scholar]
61. Moxon E.R., Rappuoli R. 1990; Modern vaccines: Haemophilus influenzae and whooping cough.. Lancet 335:1324–1329
    [Google Scholar]
62. Muller P., Keller M., Weng M., Quandt J., Arnold W., Puhler A. 1993; Genetic analysis of the Rhizobium meliloti exo YFQ operon: ExoY is homologous to sugar transferases and ExoQ represents a transmembrane protein.. Mol Plant-Microbe Interact 6:55–65
    [Google Scholar]
63. Ophir T., Gutnick D.L. 1994; A role for exopolysaccharides in the protection of micro-organisms from desiccation.. Appl Environ Microbiol 60:740–745
    [Google Scholar]
64. Ørskov I., Ørskov F., Jann B., Jann K. 1977; Serology, chemistry and genetics of O and K antigens of Escherichia coli.. Bacteriol Rev 41:667–710
    [Google Scholar]
65. Pavelka M.S., Wright L., Silver K.P. 1991; Identification of two genes, kpsM and kpsT, in region 3 of the polysialic gene cluster of Escherichia coli Kl.. J Bacteriol 173:4603–4610
    [Google Scholar]
66. Pavelka M.S., Hayes S.F., Silver R.P. 1994; Characterisation of KpsT, the ATP-binding component of the ABC-transporter involved in the export of capsular polysialic acid in Escherichia coli Kl.. J Biol Chem 269:20149–20158
    [Google Scholar]
67. Pazzani C., Rosenow C., Boulnois G.J., Bronner D., Jann K., Roberts I.S. 1993a; Molecular analysis of region 1 of the Escherichia coli K5 antigen gene cluster: a region encoding proteins involved in cell surface expression of capsular polysaccharide.. J Bacteriol 175:5978–5983
    [Google Scholar]
68. Pazzani C., Smith A., Jann K., Boulnois G.J., Roberts I.S. 1993b; The export of capsular polysaccharides in Escherichia coli.. In Polysialic Acid from Microbes to Man pp. 113–125 Roth J., Rutishauser U., Troy F.A. Edited by Basel: Birkhauser-Verlag;
    [Google Scholar]
69. Pearce R., Roberts I.S. 1995; Cloning and analysis of the gene clusters for production of the Escherichia coli K10 and K54 antigens: identification of a new group of serA-linked capsule gene clusters.. J Bacteriol 177:3992–3997
    [Google Scholar]
70. Petit C., Rigg G., Pazzani C., Smith A., Sieberth V., Stevens M., Boulnois G.J., Jann K., Roberts I.S. 1995; Analysis of region 2 of the Escherichia coli K5 capsule gene cluster: a region encoding proteins for the biosynthesis of the K5 polysaccharide.. Mol Microbiol (in press)
    [Google Scholar]
71. Peyron J.G., Balazs E.A. 1974; Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints.. Pathol Biol 22:731–736
    [Google Scholar]
72. Reizer J., Reizer A., Saier M.H. 1992; A new subfamily of bacterial ABC-type transport systems catalysing export of drugs and carbohydrates.. Protein Sci 1:1232–1236
    [Google Scholar]
73. Rinaudo M., Milas M. 1987; On the properties of poly-saccharides. Relation between chemical structure and physical properties.. In Industrial Polysaccharides. Progress in Biotechnology pp. 217–223 Yalpani M. Edited by Amsterdam: Elsevier;
    [Google Scholar]
74. Robbins J.B. 1978; Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.. Immunochemistry 15:839–854
    [Google Scholar]
75. Robbins J.B., Schneerson R. 1990; Polysaccharide-protein conjugates: a new generation of vaccines.. J Infect Dis 161:821–832
    [Google Scholar]
76. Robbins J.R., Austrian R., Lee C.-J., Rastogi S.C., Schiffman G., Henrichsen J., Makela P.H., Broome C.V., Facklam R.R., Tiesjema R.H., Parke J.C. 1983; Considerations for formulating the second-generation pneumococcal polysaccharide vaccine with emphasis on cross-reactive types within groups.. J Infect Dis 148:1136–1159
    [Google Scholar]
77. Roberts I.S., Mountford R., High N., Bitter-Suermann D., Jann K., Timmis K.N., Boulnois G.J. 1986; Molecular cloning and analysis of genes for the production of the K5, K7, K12 and K92 capsular polysaccharides in Escherichia coli.. J Bacteriol 168:1228–1233
    [Google Scholar]
78. Roberts I.S., Mountford R., Hodge R., Jann K., Boulnois G.J. 1988; Common organization of gene clusters for production of different capsular polysaccharides (K antigens) in Escherichia coli.. J Bacteriol 170:1305–1310
    [Google Scholar]
79. Roberts I.S., Saunders F.K., Boulnois G.J. 1989; Bacterial capsules and interactions with complement and phagocytes.. Biochem Soc Trans 17:462–464
    [Google Scholar]
80. Rosenow C., Esumeh F., Roberts I.S., Jann K. 1995; Characterization and localization of the KpsE protein of Escherichia coli K5, which is involved in polysaccharide export.. J Bacteriol 177:1137–1143
    [Google Scholar]
81. Ruoff K.L. 1991; The genus Streptococcus- Medical.. In The Prokaryotes pp. 1450–1464 Balows A., Truper H.G., Dworkin M., Harder W., Schleifer K.-H. Edited by New York: Springer- Verlag;
    [Google Scholar]
82. Santosham M., Wolff M., Reid R., Hohenboken M. 1991; The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.. New Engl J Med 324:1767–1772
    [Google Scholar]
83. Silver R.P., Vann W.F., Aaronson W. 1987; Translocation of capsular polysaccharide in pathogenic strains of Escherichia coli requires a 60-kilodalton periplasmic protein.. J Bacteriol 169:5489–5495
    [Google Scholar]
84. Skjaek-Braek G., Martinsen A. 1991; Applications of some algal polysaccharides in biotechnology.. In Seaweed Resources in Europe-. Uses and Potential pp. 219–257 Guiry M.D., Blunden G. Edited by London: Wiley;
    [Google Scholar]
85. Smith A.N., Boulnois G.J., Roberts I.S. 1990; Molecular analysis of the Escherichia coli K5 kps locus: identification and characterization of an inner-membrane capsular polysaccharide transport system.. Mol Microbiol 4:1863–1869
    [Google Scholar]
86. Stevens P., Huang S.N.H., Welch W.D., Young L.S. 1978; Restricted complement activation by Escherichia coli with the K1 capsular serotype: a possible role in pathogenicity.. J Immunol 121:2171–2180
    [Google Scholar]
87. Sutherland I.W. 1991 Biotechnology of Microbial Exopolysaccharides. Cambridge: Cambridge University Press.;
    [Google Scholar]
88. Swann D.A. 1968; Studies on hyaluronic acid II. The protein components of rooster comb hyaluronic acid.. Biochim Biophys Acta 160:96–105
    [Google Scholar]
89. Swann D.A., Radin E.L., Nazimiec M., Weisser P.A., Curran N., Lewinnek G. 1974; Role of hyaluronic acid in joint lubrication.. Ann Rheum Dis 33:318–326
    [Google Scholar]
90. Vann W.F., Schmidt M.A., Jann B., Jann K. 1981; Thestructure of the capsular polysaccharide (K5 antigen) of urinary tract infective Escherichia coli O10:K5:H4. A polymer similar to desulfo-heparin.. Eur J Biochem 116:359–364
    [Google Scholar]
91. Vimr E.R., Aaronson W., Silver R.P. 1989; Genetic analysis of chromosomal mutations in the polysialic gene cluster of Escherichia coli Kl.. J Bacteriol 171:1106–1117
    [Google Scholar]
92. Wyle F.A., Artenstein M.S., Brandt B.L., Tramont E.C., Kapser D.L., Altieri P.L., Berman S.L., Lowenthal J.P. 1972; Immunologic response of man to group B meningococcal polysaccharide vaccines.. J Infect Dis 126:514–521
    [Google Scholar]
93. Yamada M., Yamada Y., Saier M.H. 1990; Nucleotide sequence and expression of the gutQ gene within the glucitol operon of Escherichia coli.. J DNA Seq Map 1:141–145
    [Google Scholar]
94. Zapata G., Vann W.F., Aaronson W., Lewis M.S., Moos M. 1989; Sequence of the cloned Escherichia coli Kl CMP-N-acetyl neuraminic acid synthetase gene.. J Biol Chem 264:14769–14774
    [Google Scholar]